All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99


Breast Cancer: A Review of Mammography and Clinical Breast Examination for Early Detection of Cancer

DOI: 10.4236/oalib.1106866, PP. 1-19

Subject Areas: Oncology

Keywords: Breast Cancer, Risk, Cancer Screening, Mammography, CBE, Detection and Treatment

Full-Text   Cite this paper   Add to My Lib


Worldwide, breast cancer is one of the most common causes of death among women. Undoubtedly, early detection of breast cancer is one of the best ways to manage and treat the disease. According to literature, Mammography and Clinical breast exams are known to be some of the best methods in early detection of breast cancer. Hence information on these two detection methods is very important for planning health policies. This study therefore aimed at reviewing the literature on breast cancer as well as examining the literature on two breast cancer detection methods and their effectiveness. Statistics show that early detection is a primary necessity in the treatment of breast cancer among women. It was also found out that mammography as being the most recommended form of detection, is mostly not available at remote areas in developing countries leading to the increased risk of deaths and hence the greater mortality in these areas. Inexperience and luck of professional know-how have been found to also contribute to the upsurge of cases at developing regions. The review recommends that stakeholders and governmental bodies should help equip such areas with mammography equipment, professional knowledge on its usage. The study also, recommends that further studies be conducted to find out the relationship between various screening methods and age groups to clarify the issue of false positives and false negatives. Also, studies should be conducted on the knowledge and usage of mammographic screening in rural areas of developing centuries.

Cite this paper

Balali, G. I. , Yar, D. D. , Dela, V. G. A. , Effah-Yeboah, E. , Asumang, P. , Akoto, J. D. and Abdallah, F. (2020). Breast Cancer: A Review of Mammography and Clinical Breast Examination for Early Detection of Cancer. Open Access Library Journal, 7, e6866. doi:


[1]  Li, J., Gao, W., Yu, L.-X., Zhu, S.-Y. and Cao, F.-L. (2017) Breast-Related Stereotype Threat Contributes to a Symptom Cluster in Women with Breast Cancer. Journal of Clinical Nursing, 26, 1395-1404.
[2]  O’Mahony, M., Comber, H., Fitzgerald, T., Corrigan, M.A., Fitzgerald, E., Grunfeld, E.A., Flynn, M.G. and Hegarty, J. (2017) Interventions for Raising Breast Cancer Awareness in Women. Cochrane Database of Systematic Reviews, No. 2, Article ID: CD011396.
[3]  Organization, W.H. (2019) Global Status Report on Alcohol and Health 2018. World Health Organization, Geneva.
[4]  Smith, R.A., et al. (2016) Cancer Screening in the United States, 2016: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening. CA: A Cancer Journal for Clinicians, 66, 95-114.
[5]  Doss, M. (2016) Changing the Paradigm of Cancer Screening, Prevention, and Treatment. Dose-Response, 14, 1559325816680539.
[6]  Coleman, C. (2017) Early Detection and Screening for Breast Cancer. In Seminars in Oncology Nursing. Seminars in Oncology Nursing, 33, 141-155.
[7]  Runowicz, C.D., et al. (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA: A Cancer Journal for Clinicians, 66, 43-73.
[8]  Bray, F., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
[9]  Torre, L.A., Siegel, R.L., Ward, E.M. and Jemal, A. (2016) Global Cancer Incidence and Mortality Rates and Trends—An Update. Cancer Epidemiology and Prevention Biomarkers, 25, 16-27.
[10]  Sherman, S. and Okungu, V. (2018) Access to Breast Cancer Treatment Services in Mombasa County, Kenya: A Quality of Care Analysis of Patient and Survivor Experiences. American Journal of Public Health, 6, 189-194.
[11]  Siu, A.L. (2016) Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 164, 279-296.
[12]  Smith, R.A., et al. (2017) Cancer Screening in the United States, 2017: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening. CA: A Cancer Journal for Clinicians, 67, 100-121.
[13]  Takkar, N., Kochhar, S., Garg, P., Pandey, A.K., Dalal, U.R. and Handa, U. (2017) Screening Methods (Clinical Breast Examination and Mammography) to Detect Breast Cancer in Women Aged 40-49 Years. Journal of Mid-Life Health, 8, 2-10.
[14]  Wellings, E., Vassiliades, L. and Abdalla, R. (2016) Breast Cancer Screening for High-Risk Patients of Different Ages and Risk-Which Modality Is Most Effective? Cureus, 8, e945.
[15]  Seely, J. and Alhassan, T. (2018) Screening for Breast Cancer in 2018—What Should We Be Doing Today? Current Oncology, 25, S115-S124.
[16]  Saslow, D., et al. (2007) American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography. CA: A Cancer Journal for Clinicians, 57, 75-89.
[17]  U.S. Preventive Services Task Force (2009) Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 151, 716.
[18]  Ferlay, J., et al. (2019) Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. International Journal of Cancer, 144, 1941-1953.
[19]  International Agency for Research on Cancer (2018) Global Cancer Observatory. World Health Organization.
[20]  Percik, R., et al. (2009) Obesity and Cancer. Experimental and Clinical Endocrinology & Diabetes, 117, 563-566.
[21]  Angahar, L.T. (2017) An Overview of Breast Cancer Epidemiology, Risk Factors, Pathophysiology, and Cancer Risks Reduction. MOJ Biology and Medicine, 1, 92-96.
[22]  Kushi, L.H., et al. (2012) American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer with Healthy Food Choices and Physical Activity. CA: A Cancer Journal for Clinicians, 62, 30-67.
[23]  Abdulrahman, G.O. and Rahman, G.A. (2012) Epidemiology of Breast Cancer in Europe and Africa. Journal of Cancer Epidemiology, 2012, Article ID: 915610.
[24]  Metcalfe, K., et al. (2009) Breast Cancer Risks in Women with a Family History of Breast or Ovarian Cancer Who Have Tested Negative for a BRCA1 or BRCA2 Mutation. British Journal of Cancer, 100, 421-425.
[25]  Hilakivi-Clarke, L. (2000) Estrogens, BRCA1, and Breast Cancer. Cancer Research, 60, 4993-5001.
[26]  Kapoor, N.S., et al. (2015) Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and Has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer. Annals of Surgical Oncology, 22, 3282-3288.
[27]  Gage, M., Wattendorf, D. and Henry, L. (2012) Translational Advances Regarding Hereditary Breast Cancer Syndromes. Journal of Surgical Oncology, 105, 444-451.
[28]  Wong, E.M., et al. (2011) Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer. Cancer Prevention Research, 4, 23-33.
[29]  Berkey, C.S., et al. (2012) Young Women with Family History of Breast Cancer and Their Risk Factors for Benign Breast Disease. Cancer, 118, 2796-2803.
[30]  Saggu, S., et al. (2015) Recent Incidence and Descriptive Epidemiological Survey of Breast Cancer in Saudi Arabia. Saudi Medical Journal, 36, 1176-1180.
[31]  Kruk, J. and Czerniak, U. (2013) Physical Activity and Its Relation to Cancer Risk: Updating the Evidence. Asian Pacific Journal of Cancer Prevention, 14, 3993-4003.
[32]  Renehan, A.G., Zwahlen, M. and Egger, M. (2015) Adiposity and Cancer Risk: New Mechanistic Insights from Epidemiology. Nature Reviews Cancer, 15, 484-498.
[33]  Miller, K.D., et al. (2016) Cancer Treatment and Survivorship Statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 271-289.
[34]  Mallory, M.A. and Golshan, M. (2018) Examination Techniques: Roles of the Physician and Patient in Evaluating Breast Disease. In: Bland, K.I., et al., Eds., The Breast, Elsevier, Amsterdam, 331-336. E2.
[35]  Bibbins-Domingo, K., Grossman, D.C. and Curry, S.J. (2017) The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: an Invitation to Review and Comment. JAMA, 317, 1949-1950.
[36]  Desantis, C.E., et al. (2016) Breast Cancer Statistics, 2015: Convergence of Incidence Rates between Black and White Women. CA: A Cancer Journal for Clinicians, 66, 31-42.
[37]  Verma, B. and Zakos, J. (2001) A Computer-Aided Diagnosis System for Digital Mammograms Based on Fuzzy-Neural and Feature Extraction Techniques. IEEE Transactions on Information Technology in Biomedicine, 5, 46-54.
[38]  Highnam, R. and Brady, J.M. (2012) Mammographic Image Analysis. Springer Science & Business Media, Berlin.
[39]  Sosu, E.K. (2018) Optimization of Radiological Protection of Patients Undergoing Mammography Examination in Ghana. University of Cape Coast, Cape Coast.
[40]  Byers, T., et al. (2016) the American Cancer Society Challenge Goal to Reduce US Cancer Mortality by 50% between 1990 and 2015: Results and Reflections. CA: A Cancer Journal for Clinicians, 66, 359-369.
[41]  L?berg, M., Lousdal, M.L., Bretthauer, M. and Kalager, M. (2015) Benefits and Harms of Mammography Screening. Breast Cancer Research, 17, Article No. 63.
[42]  Pitcher, R.D. (2019) The Role of Radiology in Global Health, in Radiology in Global Health. Springer, Berlin, 157-174.
[43]  Coles, C., et al. (2017) Partial Breast Radiotherapy After Breast Conservation Surgery for Early Breast Cancer: 5-Year Outcomes from the IMPORT LOW (CRUK/06/003) Phase III Randomised Controlled Trial.
[44]  Da Costa Vieira, R.A., et al. (2017) Breast Cancer Screening in Developing Countries. Clinics, 72, 244-253.
[45]  Omidiji, O.A., et al. (2017) Breast Cancer Screening in a Resource Poor Country: Ultrasound versus Mammography. Ghana Medical Journal, 51, 6-12.
[46]  Torre, L.A., et al. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108.
[47]  Bonsu, A.B. and Ncama, B.P. (2019) Recognizing and Appraising Symptoms of Breast Cancer as a Reason for Delayed Presentation in Ghanaian Women: A Qualitative Study. PLoS ONE, 14, e0208773.
[48]  Smith, P., et al. (2018) Feasibility and Acceptability of a Cancer Symptom Awareness Intervention for Adults Living in Socioeconomically Deprived Communities. BMC Public Health, 18, Article No. 695.
[49]  Dragun, A.E., et al. (2013) Increasing Use of Elective Mastectomy and Contralateral Prophylactic Surgery among Breast Conservation Candidates: A 14-Year Report from a Comprehensive Cancer Center. American Journal of Clinical Oncology, 36, 375-380.
[50]  Elmore, J.G., et al. (2005) Screening for Breast Cancer. JAMA, 293, 1245-1256.
[51]  Girish, C., et al. (2014) A Review on Breast Cancer. International Journal of Pharma and Bio Sciences, 4, 47-54.
[52]  Bae, Y.H. andPark, K. (2011) Targeted Drug Delivery to Tumors: Myths, Reality and Possibility. Journal of Controlled Release, 153, 198-205.
[53]  Sharma, G.N., et al. (2010) Various Types and Management of Breast Cancer: an Overview. Journal of Advanced Pharmaceutical Technology & Research, 1, 109-126.
[54]  Jung, B.F., et al. (2003) Neuropathic Pain Following Breast Cancer Surgery: Proposed Classification and Research Update. Pain, 104, 1-13.
[55]  Khan, F.M. and Gibbons, J.P. (2014) Khan’s the Physics of Radiation Therapy. Lippincott Williams & Wilkins, Philadelphia.
[56]  Baskar, R., et al. (2012) Cancer and Radiation Therapy: Current Advances and Future Directions. International Journal of Medical Sciences, 9, 193-199.
[57]  Whelan, T.J., et al. (2010) Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. New England Journal of Medicine, 362, 513-520.
[58]  Cheung-Ong, K., Giaever, G. and Nislow, C. (2013) DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology. Chemistry & Biology, 20, 648-659.
[59]  Beral, V., et al. (2011) Breast Cancer Risk in Relation to the Interval between Menopause and Starting Hormone Therapy. Journal of the National Cancer Institute, 103, 296-305.
[60]  Kwak, J.J., et al. (2015) Cancer Immunotherapy: Imaging Assessment of Novel Treatment Response Patterns and Immune-Related Adverse Events. Radiographics, 35, 424-437.
[61]  Ray, K.M., et al. (2018) Screening Mammography in Women 40-49 Years Old: Current Evidence. American Journal of Roentgenology, 210, 264-270.
[62]  Feig, S.A. (2016) Assessment of New American Cancer Society Guidelines for Screening Mammography. Breast Diseases: A Year Book Quarterly, 27, 251-254.
[63]  Dombrovskiy, V. and Khachatryan, G. (2017) Comparison of Recommended Screening Programs in the United States, Canada, the Netherlands and Germany. PHARMACOECONOMICS. Modern Pharmacoeconomics and Pharmacoepidemiology, 9, 46-53.
[64]  Mitra, P. (2016) Computer Based Analysis of Mammogram Images to Treat Breast Cancer. Wichita State University, Wichita.
[65]  Smith, R.A., Cokkinides, V. and Brawley, O.W. (2012) Cancer Screening in the United States, 2012: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening. CA: A Cancer Journal for Clinicians, 62, 129-142.
[66]  Moss, S.M., et al. (2006) Effect of Mammographic Screening from Age 40 Years on Breast Cancer Mortality at 10 Years’ Follow-Up: A Randomised Controlled Trial. The Lancet, 368, 2053-2060.
[67]  Narod, S.A. (2012) Breast Cancer in Young Women. Nature Reviews Clinical Oncology, 9, 460-470.
[68]  Rivers, D., et al. (2013) A Systematic Review of the Factors Influencing African Americans’ Participation in Cancer Clinical Trials. Contemporary Clinical Trials, 35, 13-32.
[69]  Centers for Disease Control and Prevention (CDC) (2007) Use of Mammograms among Women Aged > or = 40 Years—United States, 2000-2005. MMWR. Morbidity and Mortality Weekly Report, 56, 49.
[70]  Helvie, M.A. and Bevers, T.B. (2018) Screening Mammography for Average-Risk Women: the Controversy and NCCN’s Position. Journal of the National Comprehensive Cancer Network, 16, 1398-1404.


comments powered by Disqus

Contact Us


微信:OALib Journal